Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
No fee travel points cards often provide unique perks. Discover how these benefits can maximize your travel rewards.
19,690 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
As oil approaches the $100 threshold, major energy producers could boost dividends and buybacks. Here's which names c...
Citi lifts its TMUS price target to $225, citing robust cash flow and a big buyback. The call comes as investors weig...
Is a stock market crash 2026? on the horizon. This guide translates fear into a concrete action plan—emergency funds,...
Wages have begun to catch up with the cost of living, but many households still feel the squeeze as housing, grocerie...
A high-stakes Senate hearing over Iran policy put the spotlight on intelligence briefings and political risk. The key...
U.S. banks have shifted a large portion of lending to shadow lenders, sparking debate about a repeat of 2008. Analyst...
As AI accelerates, blue-collar automation could reshape factory floors. This piece examines which robotics stocks sta...
SoundHound AI’s stock fell 6% to dip below $7 after the CFO resigns, with NVIDIA expanding edge AI ties. The move hig...
Federal regulators are pulling nearly 90,000 bottles of children's ibuprofen from shelves after reports of foreign ma...
When oil prices spike, the market story often shifts. This piece uses prices skyrocketing years history to explore wh...
When headlines shout that Bitcoin is dead, smart investors reset the math. Here’s a practical plan to invest $500 tod...